Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver.

× No keyword cloud information.

90 in total

1. Quantitative prediction of in vivo drug-drug interactions from in vitro data based on physiological pharmacokinetics: use of maximum unbound concentration of inhibitor at the inlet to the liver.

Authors: S Kanamitsu; K Ito; Y Sugiyama
Journal: Pharm Res Date: 2000-03 Impact factor: 4.200

2. Drug Interactions with Antiretrovirals.

Authors:
Journal: Curr Infect Dis Rep Date: 2000-06 Impact factor: 3.725

3. Prediction of in vivo interaction between triazolam and erythromycin based on in vitro studies using human liver microsomes and recombinant human CYP3A4.

Authors: S Kanamitsu; K Ito; C E Green; C A Tyson; N Shimada; Y Sugiyama
Journal: Pharm Res Date: 2000-04 Impact factor: 4.200

4. Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption--theoretical approach.

Authors: K Ito; H Kusuhara; Y Sugiyama
Journal: Pharm Res Date: 1999-02 Impact factor: 4.200

5. Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?

Authors: Kiyomi Ito; Koji Chiba; Masato Horikawa; Michi Ishigami; Naomi Mizuno; Jun Aoki; Yasumasa Gotoh; Takafumi Iwatsubo; Shin-ichi Kanamitsu; Motohiro Kato; Iichiro Kawahara; Kayoko Niinuma; Akiko Nishino; Norihito Sato; Yuko Tsukamoto; Kaoru Ueda; Tomoo Itoh; Yuichi Sugiyama
Journal: AAPS PharmSci Date: 2002

6. In vitro drug-drug interactions with perospirone and concomitantly administered drugs in human liver microsomes.

Authors: Jin Shimakura; Naoko Tani; Yoshiko Mizuno; Setsuko Komuro; Hiroshi Kanamaru
Journal: Eur J Drug Metab Pharmacokinet Date: 2003 Jan-Mar Impact factor: 2.441

Review 7. Database analyses for the prediction of in vivo drug-drug interactions from in vitro data.

Authors: Kiyomi Ito; Hayley S Brown; J Brian Houston
Journal: Br J Clin Pharmacol Date: 2004-04 Impact factor: 4.335

8. Impact of ignoring extraction ratio when predicting drug-drug interactions, fraction metabolized, and intestinal first-pass contribution.

Authors: Brian J Kirby; Jashvant D Unadkat
Journal: Drug Metab Dispos Date: 2010-08-19 Impact factor: 3.922

9. Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: comparison of dynamic and static models.

Authors: Eleanor J Guest; Karen Rowland-Yeo; Amin Rostami-Hodjegan; Geoffrey T Tucker; J Brian Houston; Aleksandra Galetin
Journal: Br J Clin Pharmacol Date: 2011-01 Impact factor: 4.335

10. Involvement of CYP2C9 and UGT2B7 in the metabolism of zaltoprofen, a nonsteroidal anti-inflammatory drug, and its lack of clinically significant CYP inhibition potential.

Authors: Shigeru Furuta; Nobuyoshi Akagawa; Emiko Kamada; Akio Hiyama; Yoshihiro Kawabata; Nobuhiko Kowata; Atsuhiro Inaba; Anne Matthews; Michael Hall; Tadashi Kurimoto
Journal: Br J Clin Pharmacol Date: 2002-09 Impact factor: 4.335